AbbVie Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
1.51 B |
Public Float |
1.39 B |
AbbVie Inc. | |
Stock Exchange | Mexican Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
1.51 B |
Public Float |
1.39 B |
AbbVie Inc. | |
Stock Exchange | New York Stock Exchange |
EPS |
$3.49 |
Market Cap |
$107.91 B |
Shares Outstanding |
1.48 B |
Public Float |
1.47 B |
Address |
1 North Waukegan Road North Chicago Illinois 60064 United States |
Employees | - |
Website | http://www.abbvie.com |
Updated | 07/08/2019 |
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL. |